SLS vs SNDX Stock Comparison

SLS currently leads SNDX in this stock comparison, with AIQ scores of 57 vs 43. The clearest difference is momentum, while SNDX has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 14 points
SLS
Healthcare
vs
SNDX
Healthcare
SLS
SELLAS Life Sciences Group, Inc.
Leads
Price
$7.86
Day move
-2.12%
AIQ Score
57/100
Best edge
Momentum
Sector
Healthcare
SNDX
Syndax Pharmaceuticals, Inc.
Price
$9.45
Day move
-0.94%
AIQ Score
43/100
Best edge
Risk Resilience
Sector
Healthcare

What is the main difference between SLS and SNDX?

SLS leads the current stock comparison as SELLAS Life Sciences Group, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

SELLAS Life Sciences Group, Inc. vs Syndax Pharmaceuticals, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 60/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 5/10

SLS leads

SLS leads by 14 AIQ points, primarily on Momentum and Quality, but the lead has narrowed from 26 points over 30 sessions.

Fragile: 2 of 4 evidence groups support SLS, its lead is narrowing, and its current signal state is conflicted.

Evidence agreement: 2 of 4Comparison trend: Weakening
SLS

SELLAS Life Sciences Group, Inc.

Leads
AIQ Score
57/100
AIQ Edge Score
9/10
SNDX

Syndax Pharmaceuticals, Inc.

AIQ Score
43/100
AIQ Edge Score
2/10

The Algovestiq AIQ Score currently favors SLS over SNDX, 57 versus 43 as of Nov 15, 2026. SLS's advantage is driven primarily by stronger momentum and quality, while SNDX holds the stronger risk resilience profile. SLS also shows the stronger technical structure relative to its 50-day moving average. 2 of 4 covered evidence groups favor SLS today, and the comparison is rated Fragile on stability: only 2 of 4 covered evidence groups agree. SLS lead: Weakening — the AIQ differential moved from 26 to 14 points over 30 sessions.

Compare SELLAS Life Sciences Group, Inc. and Syndax Pharmaceuticals, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

SLS
+11.2%
SNDX
-47.0%

Price return comparison

Growth of $10,000, price only

SLS $11,117 · SNDX $5,303

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare SLS and SNDX against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

SLS advantage
0
SNDX advantage
  • Momentum55 vs 14
    SLS +41
  • Quality73 vs 66
    SLS +7
  • Risk Resilience32 vs 37
    SNDX +5

2 of 4 evidence groups favor SLS. SLS’s edge is concentrated in momentum and quality; SNDX keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

SLS0 AIQ

Largest factor move: Momentum +2, not enough on its own to move the overall score.

New signals

  • Distribution Pattern — bearish, volume, medium horizon (1.48x)
SNDX+1 AIQ

Largest factor move: Value +2

No signal started or stopped since the prior session; its 7 active signals are unchanged.

SLS's lead narrowed by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — SLS and SNDX both carry a full feed there.

The central trade-off

SLS (SELLAS Life Sciences Group, Inc.): the stronger current systematic profile, led by momentum and quality.

SNDX (Syndax Pharmaceuticals, Inc.): the counter-case, on risk resilience, fundamentals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

SLS

SLS on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

SNDX

SNDX on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

SLS

SLS on the Momentum factor, by 41 points.

Lower downside

SNDX

SNDX on Risk Resilience, by 5 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureSLSSNDXNote
Implied upside to target—+288.9%Level
Target dispersion—+27.2%Lower is tighter analyst agreement
ConsensusStrong BuyBuyContext, not a primary driver
Analysts covering212Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

2 of 4 covered evidence groups favor SLS. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreSLS57 vs 43
FundamentalsSNDXEPS growth 0% vs 0%; TTM ROE -7.7% vs 287.7%
ValuationNot coveredNot covered
TechnicalsSLSPrice vs 50-day -28.7% vs -38.1%; vs 200-day -10.5% vs -52.1%
Risk ResilienceSNDXRisk Resilience 32 vs 37
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of SLS and SNDX and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is wide at 14 points. (supports the conclusion holding)
  • Only 2 of 4 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on SLS.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

SLS lead: Weakening — the AIQ differential moved from 26 to 14 points over 30 sessions.

May 27SLS leads above the line · SNDX leads belowNov 13
Today
SLS +14
57 vs 43
7 sessions ago
SLS +21
65 vs 44
30 sessions ago
SLS +26
69 vs 43
90 sessions ago
SLS +23
76 vs 53

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

SLSConflicted

1 bullish / 2 bearish / 1 neutral, conflicted

Only SLS

  • Golden Cross Active — bullish, trend, long horizon (25.60%)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • Distribution Pattern — bearish, volume, medium horizon (1.48x)
SNDXConflicted

1 bullish / 4 bearish / 2 neutral, conflicted

Only SNDX

  • Death Cross Active — bearish, trend, long horizon (29.12%)
  • 52-Week Low Proximity — bearish, risk_regime, long horizon (0.0%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Downtrend Structure Active — bearish, trend, long horizon
  • Keltner Channel Breakdown — bearish, volatility, short horizon
  • RSI Oversold — bullish, momentum, short horizon

Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.

SLS leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

SLSNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.12%, AIQ 0 points).

SNDXDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -0.94%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1SNDX closes the Momentum gap — currently 41 points behind, the largest single contributor to SLS's edge.
  2. 2SNDX's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3SLS's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once.
  4. 4The narrowing continues — the lead has already given back 12 points over 30 sessions, and a further 14-point move would eliminate SLS's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

SNDX leads on balance
MetricSLSSNDX
Revenue growth (YoY)0%14.4%
EPS growth (YoY)0%0%
Gross margin0%93.7%
Operating margin0%-61.7%
Return on equity (TTM)-7.7%287.7%
Debt to equity0-34.31

Performance

SLS leads 5 of 6 windows
MetricSLSSNDX
1 week (5 sessions)-6.7%-0.9%
1 month (20 sessions)-21.2%-26.7%
3 months (63 sessions)-39.5%-52.2%
6 months (126 sessions)11%-53.3%
Year to date108.5%-55%
1 year (252 sessions)427.5%-43.7%

Technicals

SLS has the stronger structure
MetricSLSSNDX
RSI (14)34.726.2
ADX (14)25.347.7
Price vs 50-day-28.7%-38.1%
Price vs 200-day-10.5%-52.1%
Volatility (1M, annualized)114.5%113.3%

Risk

SNDX is the more resilient
MetricSLSSNDX
Beta2.270.77
Sharpe ratio2.04-0.76
Sortino ratio3.43-0.97
Max drawdown-49.2%-62.7%
Current drawdown-49.2%-62.4%
Annualized volatility109.9%57.2%
Value at risk (95%)-8.9%-4.5%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, SLS or SNDX?

On the Algovestiq AIQ Score, SLS is the stronger of the two as of Nov 15, 2026, scoring 57 against SNDX's 43. The edge comes from momentum and quality. SNDX is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is SLS or SNDX the better buy right now?

SLS carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 4 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 2 of 4 covered evidence groups agree. Treat the lead as provisional.

Why does the AIQ Score favor SLS over SNDX?

The composite weights Quality, Value, Momentum and Risk Resilience. SLS leads Momentum by 41 points; SLS leads Quality by 7 points; SNDX leads Risk Resilience by 5 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, SLS or SNDX?

Analyst price targets imply not covered upside for SLS and +288.9% for SNDX. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, SLS or SNDX?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, SLS or SNDX?

SNDX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, SLS or SNDX?

SLS on the Momentum factor, by 41 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, SLS or SNDX?

SNDX is the more resilient of the two, so the other name carries the higher downside risk. SNDX on Risk Resilience, by 5 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is SLS more profitable than SNDX?

SNDX leads on the comparable margin measures — gross margin 0% vs 93.7%; operating margin 0% vs -61.7%; ttm roe -7.7% vs 287.7%.

Is SLS's lead over SNDX getting stronger or weaker?

SLS lead: Weakening — the AIQ differential moved from 26 to 14 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the SLS vs SNDX verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: SNDX closes the Momentum gap — currently 41 points behind, the largest single contributor to SLS's edge; SNDX's Death Cross Active resolves — a bearish trend rule currently active against it; SLS's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once; the narrowing continues — the lead has already given back 12 points over 30 sessions, and a further 14-point move would eliminate SLS's advantage entirely.

What do the current signals say about SLS and SNDX?

SLS: 1 bullish / 2 bearish / 1 neutral, conflicted. SNDX: 1 bullish / 4 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on SLS is Golden Cross Active (bullish, long horizon). On SNDX it is Death Cross Active (bearish, long horizon).

Compare SLS and SNDX with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.